Data compiled by Redley Lamar · ChainSifter Intelligence
5Suppliers
6Customers
3Debt Items
9Related Chains
Source-Backed Evidence Depth
XWELL, Inc. (XWEL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
15Total relationships
1Distinct source URLs
10High confidence
0.800Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
XWELL, Inc. Suppliers
Ticker
Name
Confidence
Evidence
CONCENTRIC-BY-GINKGO-BIOWORKS-HOLDINGS-INC
CONCENTRIC-BY-GINKGO-BIOWORKS-HOLDINGS-INC
90%
XpresTest began conducting bio surveillance monitoring with the Centers for Disease Control and Prevention (CDC) in collaboration with Concentric by Ginkgo Bioworks Holdings, Inc. ("Ginkgo Bioworks")…
GINKGO-BIOWORKS
GINKGO-BIOWORKS
90%
XpresTest began conducting bio surveillance monitoring with the Centers for Disease Control and Prevention (CDC) in collaboration with Concentric by Ginkgo Bioworks Holdings, Inc. ("Ginkgo Bioworks")…
Reciprocal relationship from RMTHF graph: Reciprocal relationship from XWEL graph: Reciprocal relationship from RMTHF graph: Alias reverse search [Matrix]: XWEL 10-K (2026-04-01) mentions 'Matrix' in…
TREAT-INC
TREAT-INC
80%
Turkey. Treat, which is operating through XWELL's subsidiary Treat, Inc. ("Treat") is a wellness brand that provides access to wellness services for travelers at on-site centers.
VENDOR
VENDOR
80%
On May 16, 2025, the Company entered into a sales and marketing agreement with a vendor that obligates the Company to make payments totaling $662 over the next three years.
XWELL, Inc. Customers
Ticker
Name
Confidence
Evidence
CDC
CDC
90%
XpresTest began conducting bio surveillance monitoring with the Centers for Disease Control and Prevention (CDC) in collaboration with Concentric by Ginkgo Bioworks Holdings, Inc. ("Ginkgo Bioworks")…
Reciprocal relationship from DNA graph: Reciprocal relationship from XWEL graph: Reciprocal relationship from DNA graph: Reciprocal relationship from XWEL graph: Reciprocal relationship from DNA grap…
ments are carried at fair value with the changes in fair value recorded in the consolidated statement of operations and other comprehensive loss in accordance with ASU 2016-01. The Company performs a…
DOMINARI-SECURITIES-LLC
DOMINARI-SECURITIES-LLC
62%
y us or our competitors; ● announcements by us or our competitors of significant contracts, acquisitions, strategic partnerships, capital commitments, or new technologies; ● new regulatory pronouncem…
GP-NURMENKARI-INC
GP-NURMENKARI-INC
62%
purchase price of $ 1,000 per unit and aggregate gross proceeds from the Private Placement were $ 4,000 . The Company used the net proceeds from the Private Placement for general corporate purposes. …
SEGMENT-INFORMATION-XWELL-INC
SEGMENT-INFORMATION-XWELL-INC
62%
. Unrecognized stock-based payment cost related to non-vested stock options as of December 31, 2025 and 2024 were $ 200 and $ 266 , respectively. The 2025 balance is expected to be recognized over a …
XWELL, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
XWEL-DEBT-13702
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
XWEL-DEBT-13701
Warrants outstanding: 1942131
90%
xbrl warrant detail from xbrl 2025-12-31.
XWEL-DEBT
Debt stack $8.3M
90%
Market cache reports total debt of $8.3M.
XWELL, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for XWELL, Inc..
XWELL, Inc. Ownership
Holder
Name
Confidence
Evidence
XWEL-OWNER-STRATEGIC-WEALTH-PARTNERS-LTD
Strategic Wealth Partners, Ltd.
90%
13F overlay lists Strategic Wealth Partners, Ltd. as top holder; 2 tracked holders.
